Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eye Patching as a Potential Treatment Modality for and a Possible Etiological Insight on Central Serous Retinopathy

NCT02036632 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02036632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02036632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eye Patching as a Potential Treatment Modality for and a Possible Etiological Insight on Central Serous Retinopathy
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2012
Completion date
January 31, 2015
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central serous retinopathy (csr)